免疫调节剂在小儿反复呼吸道感染治疗中的研究进展
Research Progress of Immunomodulators in the Treatment of Recurrent Respiratory Tract Infection in Children
马风桐1
作者信息
- 1. 丹阳市妇幼保健院 江苏 丹阳 212300
- 折叠
摘要
免疫调节剂在小儿反复呼吸道感染(RRTI)治疗中引起了广泛的研究兴趣.近年来,这些免疫调节剂通过调节机体免疫系统的功能,增强机体的免疫反应,从而改善小儿的抵抗力和预防呼吸道感染的发生.胸腺肽等免疫调节剂被广泛研究,并显示出在小儿RRTI治疗中的潜在应用价值.本研究对黄芪、多价抗原、胸腺肽、转移因子、重组细胞因子及细胞因子诱生剂等免疫调节剂在小儿RRTI治疗中的研究展开阐述,旨在为小儿RRTI的免疫治疗提供借鉴.
Abstract
Immunomodulators in the treatment of recurrent respiratory tract infections(RRTI)in children have attracted extensive research interest.In recent years,these immunomodulators have enhanced the immune response in body by regulating the function of the body's immune system,thereby improving the resistance of children and preventing the occurrence of respiratory infections.Immunomodulators such as thymosin have been extensively studied and have shown potential value in the treatment of RRTI in children.In this study,the research of immunomodulators such as astragalus,polyvalent antigen,thymosin,transfer factor,recombinant cytokine and cytokine inducer in the treatment of RRTI in children was elaborated,aiming to provide reference for the immunotherapy of RRTI in children.
关键词
小儿反复呼吸道感染/免疫调节剂/研究进展Key words
Recurrent respiratory tract infection in children/Immunomodulator/Research progress引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
维普
万方数据